LSE - Delayed Quote GBp

Aptamer Group PLC (APTA.L)

Compare
0.3300
0.0000
(0.00%)
At close: January 10 at 4:27:05 PM GMT
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
3/31/2020
Total Revenue
860.0000
860.0000
1,752.0000
4,036.0000
854.5680
Cost of Revenue
610.0000
610.0000
1,393.0000
1,351.0000
398.5980
Gross Profit
250.0000
250.0000
359.0000
2,685.0000
455.9700
Operating Expense
3,380.0000
3,380.0000
8,516.0000
5,261.0000
1,378.0200
Operating Income
-3,130.0000
-3,130.0000
-8,157.0000
-2,576.0000
-922.0500
Net Non Operating Interest Income Expense
-57.0000
-57.0000
-134.0000
-48.0000
-13.2680
Pretax Income
-3,141.0000
-3,141.0000
-8,298.0000
-2,638.0000
-941.2870
Tax Provision
-183.0000
-183.0000
-462.0000
-545.0000
-266.5570
Net Income Common Stockholders
-2,958.0000
-2,958.0000
-7,836.0000
-2,093.0000
-674.7300
Diluted NI Available to Com Stockholders
-2,958.0000
-2,958.0000
-7,836.0000
-2,093.0000
-674.7300
Basic EPS
-0.08
-0.01
-0.11
-0.03
-0.01
Diluted EPS
-0.08
-0.01
-0.11
-0.03
-0.01
Basic Average Shares
214,213.2020
415,107.5810
69,055.3690
64,546.6220
68,941.6940
Diluted Average Shares
214,213.2020
415,107.5810
69,055.3690
64,546.6220
68,941.6940
Total Operating Income as Reported
-3,084.0000
-3,084.0000
-8,157.0000
-2,576.0000
-922.0500
Total Expenses
3,990.0000
3,990.0000
9,909.0000
6,612.0000
1,776.6180
Net Income from Continuing & Discontinued Operation
-2,958.0000
-2,958.0000
-7,836.0000
-2,093.0000
-674.7300
Normalized Income
-2,958.0000
-2,958.0000
-7,836.0000
-2,093.0000
-674.7300
Interest Income
24.0000
24.0000
--
--
0.0370
Interest Expense
80.0000
80.0000
132.0000
46.0000
13.2190
Net Interest Income
-57.0000
-57.0000
-134.0000
-48.0000
-13.2680
EBIT
-3,061.0000
-3,061.0000
-8,166.0000
-2,592.0000
-928.0680
EBITDA
-2,816.0000
-2,816.0000
-4,765.0000
-2,137.0000
-733.5900
Reconciled Cost of Revenue
610.0000
610.0000
1,393.0000
1,351.0000
398.5980
Reconciled Depreciation
245.0000
245.0000
3,401.0000
454.0000
194.4780
Net Income from Continuing Operation Net Minority Interest
-2,958.0000
-2,958.0000
-7,836.0000
-2,093.0000
-674.7300
Normalized EBITDA
-2,816.0000
-2,816.0000
-4,765.0000
-2,137.0000
-733.5900
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0002
0.0003
3/31/2020 - 12/22/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ALT1.MX Altimmune, Inc.
148.05
0.00%
 
5KW.F SkinBioTherapeutics plc
0.1720
+1.18%
 
HQ1.MU Oruka Therapeutics Inc. R
18.60
0.00%
 
3G0.F Altimmune, Inc.
6.73
-5.92%
 
7IZ.MU Ziccum AB
0.0298
-29.72%
 
ORN.F Oryzon Genomics S.A.
1.5020
+2.18%
 
41X.F Ardelyx, Inc.
5.12
+0.16%
 
4AJ0.SG Alk-Abello A/S
19.46
+0.46%
 
CXF.F Chimerix, Inc.
3.1350
-6.00%
 
BLE.BE bluebird bio Inc
0.3708
-3.01%